Healthcare provider profile · identity verified

Michael Eli Pendleton, MD

Family Practice · LOUISVILLE, KY · NPI 1922211556

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	243	77
Amlodipine Besylate	Amlodipine Besylate	208	64
Lisinopril	Lisinopril	180	59
Levothyroxine Sodium	Levothyroxine Sodium	178	51
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	138	22
Gabapentin	Gabapentin	137	43
Rosuvastatin Calcium	Rosuvastatin Calcium	131	44
Omeprazole	Omeprazole	120	36
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	118	15
Tamsulosin Hcl	Tamsulosin Hcl	102	29
Losartan Potassium	Losartan Potassium	99	30
Trazodone Hcl	Trazodone Hcl	98	24
Hydrochlorothiazide	Hydrochlorothiazide	96	30
Simvastatin	Simvastatin	87	22
Metoprolol Succinate	Metoprolol Succinate	85	26
Escitalopram Oxalate	Escitalopram Oxalate	77	30
Lorazepam	Lorazepam	77	18
Alprazolam	Alprazolam	75	17
Pantoprazole Sodium	Pantoprazole Sodium	75	25
Zolpidem Tartrate	Zolpidem Tartrate	71	21
Montelukast Sodium	Montelukast Sodium	68	17
Sertraline Hcl	Sertraline Hcl	67	20
Synthroid	Levothyroxine Sodium	59	16
Albuterol Sulfate Hfa	Albuterol Sulfate	57	19
Bupropion Xl	Bupropion Hcl	55	15
Diazepam	Diazepam	53	15
Duloxetine Hcl	Duloxetine Hcl	52	14
Metformin Hcl	Metformin Hcl	51	20
Telmisartan	Telmisartan	51	19
Fluticasone Propionate	Fluticasone Propionate	50	25
Metformin Hcl Er	Metformin Hcl	49	16
Mounjaro	Tirzepatide	49	suppressed
Clopidogrel	Clopidogrel Bisulfate	48	16
Allopurinol	Allopurinol	46	12
Clonazepam	Clonazepam	45	suppressed
Carvedilol	Carvedilol	43	13
Meloxicam	Meloxicam	43	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	13
Potassium Chloride	Potassium Chloride	37	14
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Eliquis	Apixaban	35	13
Fluoxetine Hcl	Fluoxetine Hcl	35	15
Mirtazapine	Mirtazapine	34	11
Furosemide	Furosemide	33	16
Promethazine Hcl	Promethazine Hcl	33	suppressed
Oxycodone Hcl	Oxycodone Hcl	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	29	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Testosterone Cypionate	Testosterone Cypionate	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Estradiol Valerate	Estradiol Valerate	24	suppressed
Estradiol	Estradiol	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Prednisone	Prednisone	23	14
Triamcinolone Acetonide	Triamcinolone Acetonide	23	13
Warfarin Sodium	Warfarin Sodium	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	12
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Ramipril	Ramipril	21	suppressed
Topiramate	Topiramate	21	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Methadone Hcl	Methadone Hcl	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Ondansetron Odt	Ondansetron	18	12
Donepezil Hcl	Donepezil Hcl	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	16	suppressed
Fluconazole	Fluconazole	16	11
Ozempic	Semaglutide	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Baclofen	Baclofen	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Famotidine	Famotidine	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Valsartan	Valsartan	14	suppressed
Famciclovir	Famciclovir	13	suppressed
Finasteride	Finasteride	13	suppressed
Glipizide	Glipizide	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Colchicine	Colchicine	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Progesterone	Progesterone	11	suppressed
Selenium Sulfide	Selenium Sulfide	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error